Serum d-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker
Abstract d-Serine acts as a co-agonist of N-methyl-d-aspartate receptors (NMDAR) which appear overactivated in AD, while d-aspartate is a modulatory molecule acting on NMDAR as a second agonist. The aim of this work is to clarify whether the levels of these d-amino acids in serum are deregulated in...
Main Authors: | Luciano Piubelli, Loredano Pollegioni, Valentina Rabattoni, Marco Mauri, Lucia Princiotta Cariddi, Maurizio Versino, Silvia Sacchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-021-01202-3 |
Similar Items
-
D-SERINE AND D-ASPARTATE LEVEL IN BLOOD: NOVEL PERIPHERAL BIOMARKERS FOR PRECOCIOUS DIAGNOSIS AND PROGRESSION OF ALZHEIMER’S DISEASE?
by: Zoraide Motta, et al.
Published: (2023-10-01) -
D-Amino Acid Oxidase-pLG72 Interaction and D-Serine Modulation
by: Loredano Pollegioni, et al.
Published: (2018-01-01) -
Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
by: Lucia Princiotta Cariddi, et al.
Published: (2022-10-01) -
OMICS INSIGHTS INTO SERINE METABOLISM IN ALZHEIMER’S DISEASE
by: Valentina Rabattoni, et al.
Published: (2023-10-01) -
Depressive symptoms in amnesic mild cognitive impairment: an FDG-PET/CT study
by: Marco Mauri, et al.
Published: (2022-06-01)